Organogenesis Holdings earnings were -$13.4M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest ORGO earnings report on Sep 30, 2025 announced Q3 2025 earnings of $14.5M, down 219% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ORGO reported annual earnings of -$937.0k, with -118.9% growth.
Organogenesis Holdings Earnings Reports & History FAQ
What were Organogenesis Holdings's earnings last quarter?
On ORGO's earnings call on Invalid Date, Organogenesis Holdings (NASDAQ: ORGO) reported Q3 2025 earnings per share (EPS) of $0.11, up 22.22% year over year. Total ORGO earnings for the quarter were $14.53 million. In the same quarter last year, Organogenesis Holdings's earnings per share (EPS) was $0.09.
Is Organogenesis Holdings profitable or losing money?
As of the last Organogenesis Holdings earnings report, Organogenesis Holdings is currently profitable. Organogenesis Holdings's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $1.01 million, a 113.62% decrease year over year.
What was ORGO's earnings growth in the past year?
As of Organogenesis Holdings's earnings date in Invalid Date, Organogenesis Holdings's earnings has grown year over year. ORGO earnings in the past year totalled -$13.39 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.